China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
1.570
-0.160 (-9.25%)
At close: Jun 4, 2026, 4:00 PM EDT
1.627
+0.056 (3.60%)
After-hours: Jun 4, 2026, 6:56 PM EDT

China SXT Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
1034431129
Market Cap Growth
-75.03%819.62%14.92%-71.49%-60.18%47.16%
Enterprise Value
-9.0617.09-5.78-10.44-2.1115.24
Last Close Price
1.572.4913.4456.721120.007360.00
PS Ratio
7.1819.691.931.644.375.98
PB Ratio
0.072.220.270.220.691.79
P/TBV Ratio
9.000.230.110.130.361.66
P/FCF Ratio
----55.27-
P/OCF Ratio
----42.40-
EV/Sales Ratio
-9.81-3.00-5.29-0.813.19
EV/EBITDA Ratio
--2.501.950.43-
EV/EBIT Ratio
--2.301.860.41-
EV/FCF Ratio
--2.9868.90--
Debt / Equity Ratio
0.060.060.180.250.120.00
Debt / FCF Ratio
----9.94-
Net Debt / Equity Ratio
-0.99-1.11-0.68-0.93-0.82-0.83
Net Debt / EBITDA Ratio
2.406.594.082.542.777.18
Net Debt / FCF Ratio
7.177.294.8789.88-65.499.43
Asset Turnover
0.060.080.070.060.080.17
Inventory Turnover
1.521.692.072.001.442.21
Quick Ratio
4.003.301.501.291.201.05
Current Ratio
4.373.541.601.351.311.25
Return on Equity (ROE)
-49.73%-22.50%-21.65%-38.15%-31.37%-24.71%
Return on Assets (ROA)
-34.91%-11.97%-9.55%-17.77%-14.32%-8.32%
Return on Invested Capital (ROIC)
-352.28%-35.78%-18.29%-38.26%-35.13%-19.94%
Return on Capital Employed (ROCE)
-46.51%-17.94%-17.18%-35.62%-32.04%-17.30%
FCF Yield
----1.81%-
Buyback Yield / Dilution
--1212.67%-224.91%-541.91%-44.50%-132.78%
Total Shareholder Return
--1212.67%-224.91%-541.91%-44.50%-132.78%
SEC Filings: 10-K · 10-Q